Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer

Clinical trial NCT05626309 · UNKNOWN

Trial details

NCT number: NCT05626309
Sponsor: Jie Li
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Esophagus Cancer

Start date: 2022-10-01
Primary completion: 2024-08-30
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.